Please try another search
Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. The company was incorporated in 1991 and is headquartered in Hyderabad, India.
Name | Age | Since | Title |
---|---|---|---|
R. T. Ravi | 74 | 1992 | Non-Executive Chairman |
G. V. L. Prasad | 65 | 2004 | Independent Non-Executive Director |
Avinash Ravi | 43 | 2009 | Non-Executive Director |
Tangirala Malati | 71 | 2015 | Independent Non-Executive Director |
Satish Khivsara | 76 | 2015 | Independent Non-Executive Director |
Raj Kamal Prasad Verma | 72 | 2016 | Independent Non-Executive Director |
Jitendra Rameshchandra Shah | 55 | 2021 | MD, CEO & Director |
Pabitra Kumar Kalipada Bhattacharya | 54 | 2021 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review